- Home
- FBIO vs ONCY Comparison
FBIO vs ONCY Comparison
Compare FBIO & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBIO
- ONCY
- Stock Information
- Founded
- FBIO 2006
- ONCY 1998
- Country
- FBIO United States
- ONCY Canada
- Employees
- FBIO N/A
- ONCY N/A
- Industry
- FBIO Biotechnology: Pharmaceutical Preparations
- ONCY Pharmaceuticals and Biotechnology
- Sector
- FBIO Health Care
- ONCY Health Care
- Exchange
- FBIO Nasdaq
- ONCY Nasdaq
- Market Cap
- FBIO 49.1M
- ONCY 49.1M
- IPO Year
- FBIO N/A
- ONCY 1999
- Fundamental
- Price
- FBIO $1.88
- ONCY $0.91
- Analyst Decision
- FBIO Strong Buy
- ONCY Strong Buy
- Analyst Count
- FBIO 2
- ONCY 4
- Target Price
- FBIO $21.00
- ONCY $4.33
- AVG Volume (30 Days)
- FBIO 233.4K
- ONCY 1.4M
- Earning Date
- FBIO 08-12-2025
- ONCY 07-31-2025
- Dividend Yield
- FBIO N/A
- ONCY N/A
- EPS Growth
- FBIO N/A
- ONCY N/A
- EPS
- FBIO N/A
- ONCY N/A
- Revenue
- FBIO $57,784,000.00
- ONCY N/A
- Revenue This Year
- FBIO $51.59
- ONCY N/A
- Revenue Next Year
- FBIO $44.74
- ONCY N/A
- P/E Ratio
- FBIO N/A
- ONCY N/A
- Revenue Growth
- FBIO N/A
- ONCY N/A
- 52 Week Low
- FBIO $1.33
- ONCY $0.33
- 52 Week High
- FBIO $2.89
- ONCY $1.53
- Technical
- Relative Strength Index (RSI)
- FBIO 53.63
- ONCY 78.49
- Support Level
- FBIO $1.76
- ONCY $0.71
- Resistance Level
- FBIO $1.89
- ONCY $0.81
- Average True Range (ATR)
- FBIO 0.10
- ONCY 0.09
- MACD
- FBIO -0.01
- ONCY 0.02
- Stochastic Oscillator
- FBIO 75.00
- ONCY 90.48
About FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.